Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24155989 | 0.93 | PDK2 (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL22182360 | 0.89 | KDM4E (0.37) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL18468980 | 0.88 | KDM4E (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL22920898 | 0.88 | KDM4E (0.32) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL19299580 | 0.88 | PDK2 (0.34) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24156461 | 0.88 | KDM4E (0.35) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL22182466 | 0.88 | KDM4E (0.31) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL26753311 | 0.88 | MEN1 (0.39) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24647387 | 0.88 | KDM4E (0.33) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24156474 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210408381-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2021-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210408381-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OXER1, OR10J3, OR51E2 | KDM4E 3322/4885MEN1 3164/4885LMNA 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.